| Inhibition of recombinant CYP2C19 - BioAssay Summary Thermosensitive transient receptor potential melastatin 8 (TRPM8) antagonists are considered to be potential therapeutic agents for the treatment of cold hypersensitivity. The discovery of a new class of TRPM8 antagonists that shows in vivo efficacy in the rat chronic constriction injury (CCI)-induced model of neuropathic pain is described. ..more |
_ | |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tested Compound: Description: Title: Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia. Abstract: Thermosensitive transient receptor potential melastatin 8 (TRPM8) antagonists are considered to be potential therapeutic agents for the treatment of cold hypersensitivity. The discovery of a new class of TRPM8 antagonists that shows in vivo efficacy in the rat chronic constriction injury (CCI)-induced model of neuropathic pain is described. (PMID: 22330635) Comment Putative Target: ChEMBL Target ID: 12912 Target Type: SINGLE PROTEIN Pref Name: Cytochrome P450 2C19 Description: Cytochrome P450 2C19 Organism: Homo sapiens Tax ID: 9606 Confidence: Homologous single protein target assigned Relationship Type: Homologous protein target assigned ChEMBL target type: Target is a single protein chain Categorized Comment ChEMBL Assay Type: ADMET ChEMBL Assay Data Source: Scientific Literature Result Definitions
* Activity Concentration. Data Table (Concise)
PageFrom: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||